Please assess the completion status of the following clinical trial:

Trial Title: BG9924 in Combination With Methotrexate Extension of Study 104RA203 (NCT 00458861)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Must be a participant from Study 104RA203 (NCT 00458861)~Exclusion Criteria:~* Participants with a significant change in medical history from their previous BG9924 Study 104RA203 (NCT 00458861).~* Nursing mothers, pregnant women, or women who are planning to become pregnant while in the study.~* Male and female participants of child-bearing potential not willing to practice effective birth control for the duration of the study.~NOTE: Other protocol defined Inclusion/Exclusion criteria may apply.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- BG9924 (Type: EXPERIMENTAL): dosage administered as per Biogen-idec protocol

Based on this trial design, predict the completion outcome and termination type (if applicable).